Catalyst Wire Dossier Catalyst Wire Dossier

ACAM2000

Vaccinia vaccine (live, cell culture-derived) · Acambis plc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ACAM2000, covering 2011-02-11 to 2022-10-26. Get the full timeline:

Most recent: Clinical Trial Update: VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV [Phase 4]

See pricing